Literature DB >> 28069819

Temporal Role for MyD88 in a Model of Brucella-Induced Arthritis and Musculoskeletal Inflammation.

Carolyn A Lacey1,2, William J Mitchell1, Charles R Brown1, Jerod A Skyberg3,2.   

Abstract

Brucella spp. are facultative intracellular Gram-negative bacteria that cause the zoonotic disease brucellosis, one of the most common global zoonoses. Osteomyelitis, arthritis, and musculoskeletal inflammation are common focal complications of brucellosis in humans; however, wild-type (WT) mice infected systemically with conventional doses of Brucella do not develop these complications. Here we report C57BL/6 WT mice infected via the footpad with 103 to 106 CFU of Brucella spp. display neutrophil and monocyte infiltration of the joint space and surrounding musculoskeletal tissue. Joint inflammation is detectable as early as 1 day postinfection and peaks 1 to 2 weeks later, after which WT mice are able to slowly resolve inflammation. B and T cells were dispensable for the onset of swelling but required for resolution of joint inflammation and infection. At early time points, MyD88-/- mice display decreased joint inflammation, swelling, and proinflammatory cytokine levels relative to WT mice. Subsequently, swelling of MyD88-/- joints surpassed WT joint swelling, and resolution of joint inflammation was prolonged. Joint bacterial loads in MyD88-/- mice were significantly greater than those in WT mice by day 3 postinfection and at all time points thereafter. In addition, MyD88-/- joint inflammatory cytokine levels on day 3 and beyond were similar to WT levels. Collectively these data demonstrate MyD88 signaling mediates early inflammatory responses in the joint but also contributes to subsequent clearance of Brucella and resolution of inflammation. This work also establishes a mouse model for studying Brucella-induced arthritis, musculoskeletal complications, and systemic responses, which will lead to a better understanding of focal complications of brucellosis.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Brucella; MyD88; arthritis; brucellosis; musculoskeletal; osteomyelitis

Mesh:

Substances:

Year:  2017        PMID: 28069819      PMCID: PMC5328475          DOI: 10.1128/IAI.00961-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  57 in total

1.  Brucellosis of the bones and joints. Experience with thirty-six patients.

Authors:  P J KELLY; W J MARTIN; A SCHIRGER; L A WEED
Journal:  JAMA       Date:  1960-09-24       Impact factor: 56.272

2.  IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1).

Authors:  Zhihong Chen; Lingkai Su; Qingan Xu; Jenny Katz; Suzanne M Michalek; Mingwen Fan; Xu Feng; Ping Zhang
Journal:  J Biol Chem       Date:  2015-10-19       Impact factor: 5.157

3.  TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation.

Authors:  Ru Liu-Bryan; Kenneth Pritzker; Gary S Firestein; Robert Terkeltaub
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

4.  Resistance against a subcutaneous Brucella challenge of mice immunized with living or dead Brucella or by transfer of immune serum.

Authors:  P Pardon
Journal:  Ann Immunol (Paris)       Date:  1977 Nov-Dec

5.  A model of animal-human brucellosis transmission in Mongolia.

Authors:  J Zinsstag; F Roth; D Orkhon; G Chimed-Ochir; M Nansalmaa; J Kolar; P Vounatsou
Journal:  Prev Vet Med       Date:  2005-06-10       Impact factor: 2.670

6.  Synovial fluid from patients with early osteoarthritis modulates fibroblast-like synoviocyte responses to toll-like receptor 4 and toll-like receptor 2 ligands via soluble CD14.

Authors:  Anjali Nair; Veero Kanda; Charles Bush-Joseph; Nikhil Verma; Susan Chubinskaya; Katalin Mikecz; Tibor T Glant; Anne-Marie Malfait; Mary K Crow; Greg T Spear; Alison Finnegan; Carla R Scanzello
Journal:  Arthritis Rheum       Date:  2012-07

7.  Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice.

Authors:  Marco A Campos; Gracia M S Rosinha; Igor C Almeida; Xirlene S Salgueiro; Bruce W Jarvis; Gary A Splitter; Nilofer Qureshi; Oscar Bruna-Romero; Ricardo T Gazzinelli; Sergio C Oliveira
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Central role of MyD88-dependent dendritic cell maturation and proinflammatory cytokine production to control Brucella abortus infection.

Authors:  Gilson Costa Macedo; Diogo Matos Magnani; Natalia Barbosa Carvalho; Oscar Bruna-Romero; Ricardo T Gazzinelli; Sergio Costa Oliveira
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

9.  Articular involvement in human brucellosis: a retrospective analysis of 304 cases.

Authors:  E Gotuzzo; G S Alarcón; T S Bocanegra; C Carrillo; J C Guerra; I Rolando; L R Espinoza
Journal:  Semin Arthritis Rheum       Date:  1982-11       Impact factor: 5.532

10.  Osteoarticular complications of brucellosis.

Authors:  J D Colmenero; J M Reguera; A Fernández-Nebro; F Cabrera-Franquelo
Journal:  Ann Rheum Dis       Date:  1991-01       Impact factor: 19.103

View more
  8 in total

1.  Hematopoietic MyD88 and IL-18 are essential for IFN-γ-dependent restriction of type A Francisella tularensis infection.

Authors:  Jerod A Skyberg; Carolyn A Lacey
Journal:  J Leukoc Biol       Date:  2017-09-26       Impact factor: 4.962

2.  IFN-γ-dependent nitric oxide suppresses Brucella-induced arthritis by inhibition of inflammasome activation.

Authors:  Carolyn A Lacey; Catherine A Chambers; William J Mitchell; Jerod A Skyberg
Journal:  J Leukoc Biol       Date:  2019-02-12       Impact factor: 4.962

3.  B Cells Inhibit CD4+ T Cell-Mediated Immunity to Brucella Infection in a Major Histocompatibility Complex Class II-Dependent Manner.

Authors:  Alexis S Dadelahi; Carolyn A Lacey; Catherine A Chambers; Bárbara Ponzilacqua-Silva; Jerod A Skyberg
Journal:  Infect Immun       Date:  2020-04-20       Impact factor: 3.441

4.  Caspase-1 and Caspase-11 Mediate Pyroptosis, Inflammation, and Control of Brucella Joint Infection.

Authors:  Carolyn A Lacey; William J Mitchell; Alexis S Dadelahi; Jerod A Skyberg
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

5.  Interaction of Brucella abortus with Osteoclasts: a Step toward Understanding Osteoarticular Brucellosis and Vaccine Safety.

Authors:  Omar H Khalaf; Sankar P Chaki; Daniel G Garcia-Gonzalez; Larry J Suva; Dana Gaddy; Angela M Arenas-Gamboa
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

Review 6.  Alternative strategies for vaccination to brucellosis.

Authors:  David W Pascual; Xinghong Yang; Hongbin Wang; Zakia Goodwin; Carol Hoffman; Beata Clapp
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

7.  A genetics-led approach defines the drug target landscape of 30 immune-related traits.

Authors:  Hai Fang; Hans De Wolf; Bogdan Knezevic; Katie L Burnham; Julie Osgood; Anna Sanniti; Alicia Lledó Lara; Silva Kasela; Stephane De Cesco; Jörg K Wegner; Lahiru Handunnetthi; Fiona E McCann; Liye Chen; Takuya Sekine; Paul E Brennan; Brian D Marsden; David Damerell; Chris A O'Callaghan; Chas Bountra; Paul Bowness; Yvonne Sundström; Lili Milani; Louise Berg; Hinrich W Göhlmann; Pieter J Peeters; Benjamin P Fairfax; Michael Sundström; Julian C Knight
Journal:  Nat Genet       Date:  2019-06-28       Impact factor: 38.330

8.  MyD88-Dependent Glucose Restriction and Itaconate Production Control Brucella Infection.

Authors:  Carolyn A Lacey; Bárbara Ponzilacqua-Silva; Catherine A Chambers; Alexis S Dadelahi; Jerod A Skyberg
Journal:  Infect Immun       Date:  2021-06-14       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.